|
|
|
Volumn 6, Issue 12, 2008, Pages
|
|
KRAS mutation in metastatic colorectal cancer and its impact on the use of EGFR inhibitors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
KRAS PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
ONCOPROTEIN;
PANITUMUMAB;
RAS PROTEIN;
ARTICLE;
CLINICAL TRIAL;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
GENETICS;
HUMAN;
METASTASIS;
MUTATION;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
COLORECTAL NEOPLASMS;
HUMANS;
MUTATION;
PROTO-ONCOGENE PROTEINS;
RAS PROTEINS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 64949091729
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
